https://www.thebodypro.com/category/providing-quality-hiv-care

Providing Quality HIV Care

The Latest

monoclonal antibodies
Interviews

Are Monoclonal Antibodies the Future of COVID-19 Treatment?

Infectious-diseases researcher David Wohl, M.D., talks about a major COVID-19 treatment trial in the works—and how it relates to our efforts against HIV.

By Terri Wilder, M.S.W.
BLM health care
News

This Week in HIV Research: The Long Road to Racial Health Justice

Sept. 24, 2020: HIV adherence cohorts usually fail to reflect the diversity of the epidemic; HIV thrives in deprived neighborhoods; rethinking barriers to rapid HIV treatment initiation; long-term adverse events on INSTIs vs. efavirenz.

By Barbara Jungwirth and Myles Helfand
Juan Berenguer, M.D., Ph.D. and Antonio Urbina, M.D.
Interviews

Immediate HIV Treatment Initiation With Integrase Inhibitors Leads to Large Drop in Secondary HIV Transmission Among MSM

Integrase inhibitors are known to be potent first-line therapy options. Recent research suggests their benefits extend to onward HIV prevention as well.

By Terri Wilder, M.S.W. and Myles Helfand
disparity
News

This Week in HIV Research: Disclosing Our Disparities

Sept. 17, 2020: HIV prevalence gaps between Latinx people and non-Latinx white people; Obamacare awareness and perceptions among HIV clinicians; the relationship between pain and HIV; cancer mortality trends among PLWH.

By Barbara Jungwirth and Myles Helfand
Peter Stinner with his husband, Jeff Graham.
Interviews

Remembering Peter Stinner, a Keystone of Atlanta’s HIV Community

Stinner's husband, Jeff Graham, and colleague, Jonathan Colasanti, M.D., share a trove of stories about a person who embodied the ideals of empathy and care in HIV and health services.

By Terri Wilder, M.S.W.
Hep C virus
News

This Week in HIV Research: Hep C, That Other Epidemic Within an Epidemic

Sept. 3, 2020: A hepatitis C microelimination program for people living with HIV; PrEP concentrations and gender-affirming hormones; a collaborative intervention to improve opioid prescribing practices; TDF and fracture risk.

By Barbara Jungwirth and Myles Helfand
telehealth
Features

Getting PrEP to Those Who Need It During COVID-19 Has Presented New Challenges

Washington, D.C. area community organizations and clinics have moved a lot of prevention efforts online, but much is missing without in-person contact.

By Chase Alston
man working alone in office

Loneliness Linked to Poorer Brain Health and Reduced Quality of Life in HIV

As CATIE reports, a Canadian study found that people living with HIV were more likely to be lonely than the average person—and that loneliness grew more common the younger a person with HIV was.

By Sean R. Hosein for Canadian AIDS Treatment Information Exchange
doctor with trans patient
News

This Week in HIV Research: When Treating Trans Patients, Check Your Priors

Aug. 27, 2020: Traditional CVD risk calculation tools falter for transgender women; switching to B/F/TAF despite NRTI resistance; how tenofovir has altered the HBV landscape; syndemic effects on viral load and blood pressure.

By Barbara Jungwirth and Myles Helfand
brain dissipation
News

This Week in HIV Research: What We Don’t Know Hurts Them

Aug. 20, 2020: HIV knowledge and stigma among health care workers in the southern U.S.; condomless sex vs. HIV risk among MSM; how drug class choice may affect onward transmission risk; STI screening rates among MSM on PrEP.

By Barbara Jungwirth and Myles Helfand

Meet the Experts

Paul E. Sax, M.D. Img
Paul E. Sax, M.D.

Dr. Sax is director of the HIV Program and Division of Infectious Diseases at Brigham and Women's Hospital (BWH) in Boston.

David Alain Wohl, M.D. Img
David Alain Wohl, M.D.

David Alain Wohl, M.D., is a professor at the University of North Carolina, site leader of the UNC AIDS Clinical Trials Unit at Chapel Hill, director of the North Carolina AETC, and co-director of HIV services for the NC state prison system.